-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Roivant Sciences (ROIV)
-
-
-
-
-
-
-
Roivant Sciences (ROIV) PT Raised to $18 at H.C. Wainwright, 'brepocitinib has blockbuster potential'
-
-
22,119 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

